Suico, Abundio V.
HRN: 14-64-67 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/21/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/21/2025
05/28/2025
IV
4.5
Q6
Intraadbominal Infection
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes